UFC Heavyweight Walt Harris has accepted a four-month sanction for utilizing a banned substance. Due to his cooperation with USADA, Harris’ suspension was reduced to just four months and he will be able to return to the Octagon on April 30th.
Via USADA:
Harris, 35, tested positive for LGD-4033 as the result of an in-competition urine sample he provided on December 29, 2018 that was collected by the California State Athletic Commission (CSAC) at UFC 232 in Inglewood, Calif. LGD-4033 is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy (UFC ADP), which has adopted the World Anti-Doping Agency (WADA) Prohibited List.
Following notification of his positive test, Harris provided USADA with information about a dietary supplement product he was using before and at the time of the relevant sample collection. Although no prohibited substances were listed on the supplement label, analysis conducted on both the open and independently sourced, unopened containers of the product by the WADA-accredited laboratory in Salt Lake City, Utah, indicated that the product contained LGD-4033.
Although not stated in the report, there is an over the counter supplement known as Ligandrol which claims to build muscle mass.
Payout Perspective:
It appears that this is another case of where the athlete just didn’t know that a banned substance was in the supplement because it was not on the label of ingredients. Fortunately for Harris, he has served his short suspension without losing out on any fights as it was unlikely he’d have come back this soon after his December fight.
Leave a Reply